Optometrist · Brooklyn, NY
NPI
1679526040
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
18
Medicare group memberships
Hospitals
0
Hospital affiliations
187 Avenue U
Brooklyn, NY, 11223
Phone (718) 373-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$369K
8,577 services
Medicare patients, 2024
808
Average age 76
Drug cost, 2024
$1.5M
4,453 prescriptions
Company payments, 2025
$622
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elena Feldman was code 76512 (ultrasound - nonspecific), 1,401 times for 646 patients. In total Elena Feldman billed 8,577 services in 25 codes, and Medicare paid $369K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 76512 Ultrasound - Nonspecific | Office | 1,401 | 646 | $37.12 | $52K |
| 92285 Standard X-ray | Office | 851 | 740 | $17.20 | $15K |
| 92250 Angiography | Office | 845 | 747 | $27.70 | $23K |
| 76514 Ultrasound - Nonspecific | Office | 718 | 639 | $8.94 | $6,416 |
| 92286 Standard X-ray | Office | 703 | 630 | $29.64 | $21K |
| 92020 Ophthalmological E&M | Office | 654 | 579 | $21.63 | $14K |
| 92083 Vision, Hearing, and Speech Services | Office | 644 | 583 | $52.88 | $34K |
| 92025 Test - Miscellaneous | Office | 624 | 562 | $27.67 | $17K |
| 92014 Ophthalmological E&M | Office | 601 | 512 | $99.31 | $60K |
| 68761 Eye | Office | 474 | 138 | $95.10 | $45K |
| 92012 Ophthalmological E&M | Office | 313 | 190 | $69.67 | $22K |
| 92004 Ophthalmological E&M | Office | 267 | 267 | $115.19 | $31K |
| 92273 Test - Miscellaneous | Office | 150 | 150 | $106.22 | $16K |
| 92133 Computerized Ophthalmic Imaging | Office | 139 | 101 | $29.19 | $4,057 |
| 92134 Computerized Ophthalmic Imaging | Office | 99 | 86 | $33.01 | $3,268 |
By year: 2022 $378K for 7,742 services; 2023 $343K for 7,234 services; 2024 $369K for 8,577 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elena Feldman prescribed most often to Medicare patients was Latanoprost, with 773 prescriptions and refills. In total Elena Feldman wrote 4,453 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 773 | 1,167 | 237 | $5,264 |
| Restasis Cyclosporine | 602 | 702 | 135 | $416K |
| Xiidra Lifitegrast | 359 | 397 | 85 | $261K |
| Cyclosporine Generic | 221 | 297 | 57 | $77K |
| Erythromycin Erythromycin Base | 210 | 210 | 110 | $2,290 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 199 | 200 | 147 | $6,546 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 194 | 195 | 121 | $1,610 |
| Lumigan Bimatoprost | 193 | 333 | 41 | $94K |
| Timolol Maleate Generic | 182 | 284 | 48 | $2,209 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 168 | 295 | 63 | $2,998 |
| Vyzulta Latanoprostene Bunod | 164 | 216 | 33 | $61K |
| Azelastine Hcl Generic | 106 | 108 | 33 | $1,141 |
| Tobradex Tobramycin/Dexamethasone | 105 | 105 | 66 | $27K |
| Zerviate Cetirizine Hcl | 74 | 90 | 15 | $32K |
| Brimonidine Tartrate Generic | 71 | 90 | 17 | $5,403 |
Brand drugs: 2,484 claims; generic drugs: 1,969 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elena Feldman $622 ($622 in general payments such as food, travel and fees) from 6 companies. The largest payer was Alcon Vision LLC with $227.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 8 | $227 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $192 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $107 |
| Dompe US, Inc. | 2 | $53.87 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $23.33 |
| Johnson & Johnson Vision Care, Inc. JNJ | 1 | $19.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.